Regulatory B cells are reduced in the blood in patients with granulomatosis with polyangiitis, and fail to regulate T-cell IFN-γproductionShow others and affiliations
2023 (English)In: Clinical and Experimental Immunology, ISSN 0009-9104, E-ISSN 1365-2249, Vol. 213, no 2, p. 190-201Article in journal (Refereed) Published
Abstract [en]
Regulatory B (Breg) cells can dampen inflammation, autoreactivity, and transplant rejection. We investigated the frequencies, phenotypes, and function of Breg cells in granulomatosis with polyangiitis (GPA) to gain further knowledge as to whether there are numerical alterations or limitations of their ability to regulate T-cell function. Frequencies and phenotypes of CD24hiCD27+ and CD24hiCD38hi B-cells in the blood were determined with flow cytometry in 37 GPA patients (22 in remission and 15 with active disease) and 31 healthy controls (HC). A co-culture model was used to study the capacity of Breg cells to regulate T-cell activation and proliferation in cells from 10 GPA patients in remission and 12 HC. T-cell cytokine production in vitro and levels in plasma were determined with enzyme-linked immunosorbent assay. Frequencies of CD24hiCD27+ B-cells were reduced both during active disease and remission compared with HC (P = 0.005 and P = 0.010, respectively), whereas CD24hiCD38hi B-cells did not differ. Patient CD24hiCD27+ B-cells exhibited decreased expression of CD25 but increased expression of PD-L1 and PD-L2 during remission. B-cells from GPA patients regulated T-cell proliferation but failed to regulate interferon (IFN)-γproduction (median T-cells alone 222 ng/ml vs. T-cells + B-cells 207 ng/ml, P = 0.426). IFN-γwas also elevated in patient plasma samples (P = 0.016). In conclusion, GPA patients exhibit altered numbers and phenotypes of CD24hiCD27+ B-cells. This is accompanied by a disability to control T-cell production of Th1-type cytokines during remission, which might be of fundamental importance for the granulomatous inflammation that characterizes the chronic phase of this disease. © 2023 The Author(s). Published by Oxford University Press on behalf of the British Society for Immunology.
Place, publisher, year, edition, pages
Oxford University Press , 2023. Vol. 213, no 2, p. 190-201
Keywords [en]
B-Lymphocytes, Regulatory; Cytokines; Granulomatosis with Polyangiitis; Humans; Inflammation; Interferon-gamma; azathioprine; CD24 antigen; CD27 antigen; chemokine; cyclophosphamide; cytokine; gamma interferon; interleukin 2 receptor; interleukin 2 receptor alpha; methotrexate; mycophenolate mofetil; myeloperoxidase; prednisolone; programmed death 1 ligand 1; rituximab; cytokine; gamma interferon; adult; aged; Article; autoimmunity; B lymphocyte; B lymphocyte subpopulation; cell function; cell population; cell proliferation; clinical article; coculture; comparative study; controlled study; cytokine production; disease activity; enzyme linked immunosorbent assay; female; flow cytometry; follow up; gene expression; gene frequency; human; human cell; immunoregulation; in vitro study; male; middle aged; peripheral blood mononuclear cell; phenotype; proliferation index; protein expression; regulatory B lymphocyte; regulatory mechanism; remission; T lymphocyte; T lymphocyte activation; treatment failure; vasculitis; Wegener granulomatosis; inflammation; metabolism
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-200766DOI: 10.1093/cei/uxad021ISI: 001167051500001PubMedID: 36752779Scopus ID: 2-s2.0-85165521399OAI: oai:DiVA.org:liu-200766DiVA, id: diva2:1835930
Note
Funding Agencies|Ingrid Asps Foundation; Alfred Osterlunds Stiftelse; Reumafonden; Swedish Society of Nephrology; County Council of Ostergotland; Inga-Britt and Arne Lundberg's research foundation
2024-02-072024-02-072025-02-18